Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Braz. j. med. biol. res ; 42(8): 744-749, Aug. 2009. graf, tab
Artículo en Inglés | LILACS | ID: lil-520781

RESUMEN

Amiodarone-induced thyroid dysfunction (AITD) is a common complication of amiodarone therapy and its prevalence varies according to iodine intake, subclinical thyroid disorders and the definition of AITD. There is no consensus about the frequency of screening for this condition. We evaluated 121 patients on chronic regular intake of amiodarone (mean intake = 248.5 ± 89 mg; duration of treatment = 5.3 ± 3.9 years, range = 0.57-17 years) and with stable baseline cardiac condition. Those with noAITD were followed up for a median period of 3.2 years (range: 0.6-6.7) and the incidence rate of AITD, defined by clinical and laboratorial findings as proposed by international guidelines, was obtained (62.8 per 1000 patients/year). We applied the Coxproportional hazard model to adjust for potential confounding factors and used sensitivity analysis to identify the best screening time for follow-up. We detected thyroid dysfunction in 59 (48.7%) of the 121 patients, amiodarone-induced hypothyroidism in50 (41.3%) and hyperthyroidism in 9 (7.5%). Compared with patients without AITD, there was no difference regarding dosage or duration of therapy, heart rhythm disorder or baseline cardiac condition. During the follow-up of the 62 patients without AITD at baseline evaluation, 11 developed AITD (interquartile range, IR: 62.8 (95%CI: 31.3-112.3) cases per 1000 patients/year), 9 of them with hypothyroidism - IR: 11.4 (95%CI: 1.38-41.2), and 2 hyperthyroidism - IR: 51.3 (95%CI: 23.4-97.5). Age, gender,dose, and duration of treatment were not significant after adjustment. During the first 6 months of follow-up the incidence rate for AITD was 39.3 (9.2-61.9) cases per 1000 patients/year. These data show that AITD is quite common, and support the need for screening at 6-month intervals, unless clinical follow-up dictates otherwise or further information regarding the prognosis of untreated subclinical AITD is available.


Asunto(s)
Anciano , Humanos , Masculino , Persona de Mediana Edad , Amiodarona/efectos adversos , Antiarrítmicos/efectos adversos , Hipertiroidismo/inducido químicamente , Hipotiroidismo/inducido químicamente , Amiodarona/uso terapéutico , Antiarrítmicos/uso terapéutico , Arritmias Cardíacas/tratamiento farmacológico , Estudios de Seguimiento , Hipertiroidismo/diagnóstico , Hipotiroidismo/diagnóstico , Factores de Tiempo
2.
AMB rev. Assoc. Med. Bras ; 30(3/4): 50-2, 1984.
Artículo en Portugués | LILACS | ID: lil-20327

RESUMEN

Em 11 sevicos medicos da cidade de Salvador (Bahia) foram levantados dados das fichas ou prontuarios dos 1.084 adultos atendidos em primeiras consultas entre zero e 24 horas do dia 20/07/82. Tal levantamento visou analisar as frequencias da medida da tensao arterial ( TA ) na pratica medica de rotina e dos tratamentos efetuados nos casos de hipertensao arterial detectados. A TA foi medicada em l8,7% dos pacientes, sendo que naqueles com idade >/ 35 anos a TA foi medida em 22%. Dos 203 pacientes com TA medida, 22,7% eram hipertensos e 80,4% destes tiveram prescrito ou iniciado o tratamento. Comentou-se a necessidade da melhoria da educacao e resposabilidade medicas, a necessidade da integracao clinico-epidemiologica, alem da participacao ativa da populacao para a detecao precoce da hipertensao arterial, no sentido de minimizar a morbi-mortalidade a ela consequente


Asunto(s)
Humanos , Atención Ambulatoria , Determinación de la Presión Sanguínea , Hipertensión
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA